Management has not expressed elsewhere to which I can point other serious global pharmaceutical company interest.
I independently confirmed [what I think is] serious interest by another global player.
Provectus would not comment on the information (which did not originate from the pharma interested in PV-10) underlying my thought/belief/speculation. I want to dig further before naming the pharmaceutical company.
As Provectus approaches AACR week, things might be heating up.